Skip to main content
. 2017 Jan 15;7(1):1–11.

Table 1.

Patient Characteristics

Entire Cohort
No. patients 721
Age, yrs
    Range 41-91
    Mean 70
Gleason score
    5 5 (< 1%)
    6 89 (12%)
    7 332 (46%)
    8 135 (18%)
    9 127 (18%)
    10 9 (1%)
    Unknown 24 (3%)
Prior Treatment
    Prostatectomy 213 (30%)
        Duration since treatment (yrs)
            Range 0.2-27
            Mean/median 5.98/4
    Radiation* 251 (35%)
        Duration since treatment (yrs)
            Range 0.3-23
            Mean/median 6.86/6
    Prostatectomy + Radiation** 229 (32%)
        Duration since treatment (yrs)
            Range 0.2-27
            Mean/median 8.8/7
    ADT¥ 18 (2%)
    Cyrotherapy 5 (< 1%)
    HIFU 5 (< 1%)
PSA at imaging, ng/mL
    Range 0.22-148
    Mean/median 5.9/2.6
PSA Doubling Time, months
    Range 0.2-151
    Mean/median 6.7/4.24
PSA Velocity, ng/mL/yr
    Range 0.01-34.4
    Mean/median 0.68/0.22
*

External beam radiation and/or Brachytherapy.

**

Adjuvant or Salvage external beam radiation.

¥

Androgen Deprivation Therapy.

High Intensity Focused Ultrasound.